1-cyano-1-methylethyl beta-D-glucoside,
linamarin,
phaseolunatin,
LINAMARIN,
Phaseolunatin,
554-35-8,
UNII-H3V9RP3WLO,
2-(beta-D-Glucopyranosyloxy)-2-methylpropanenitrile,
HSDB 3507,
alpha-Hydroxyisobutyronitrile-beta-D-glucose,
H3V9RP3WLO,
1-cyano-1-methylethyl beta-D-glucoside,
BRN 0019237,
2-(beta-D-Glucopyranosyloxy)isobutyronitrile,
CHEBI:16441,
Propanenitrile, 2-(beta-D-glucopyranosyloxy)-2-methyl-,
Manihotoxin,
Linamarin min. 99%,
Spectrum_001946,
SpecPlus_000936,
AC1L1WOH,
Spectrum2_001972,
Spectrum3_001622,
Spectrum4_001668,
Spectrum5_000575,
SCHEMBL42021,
BSPBio_003283,
KBioGR_002195,
KBioSS_002500,
5-17-07-00397 (Beilstein Handbook Reference),
DivK1c_007032,
SPECTRUM1504124,
SPBio_002123,
BICL4127,
CHEMBL3039425,
DTXSID8052857,
CTK8G0586,
KBio1_001976,
KBio2_002492,
KBio2_005060,
KBio2_007628,
KBio3_002503,
ZINC3984017,
CCG-39428,
MFCD00036209,
AKOS030242445,
SDCCGMLS-0066829.P001,
NCGC00178164-01,
alpha-Hydroxyisobutyronitrile beta-D-glucose,
LS-120874,
FT-0608720,
C01594,
2-beta-d-glucopyranosyloxy-2-methylpropanenitrile,
2-(|A-D-Glucopyranosyloxy)-2-methylpropionitrile,
C-51988,
SR-05000002494,
2-(|A-D-Glucopyranosyloxy)-2-methyl-propanenitrile,
2-(beta-D-Glucopyranosyloxy)-2-methylpropionitrile,
alpha-Hydroxyisobutyronitrile beta-D-glucopyranoside,
SR-05000002494-1,
W-203090,
2-(beta-D-Glucopyranosyloxy)-2-methyl-Propanenitrile,
2-(b-D-Glucopyranosyloxy)-2-methylpropanenitrile, 9CI,
alpha-Hydroxyisobutyronitrile beta-D-glucopyranoside, >=98.0% (HPLC),
2-methyl-2-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)propanenitrile,
2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropanenitrile,
2-methyl-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanenitrile,
C10H17NO6,
CID11128,
C10-H17-N-O6,
|A-Hydroxyisobutyronitrile |A-D-glucose,
|A-Hydroxyisobutyronitrile |A-D-glucopyranoside,